leisure time -WSS

leisure time

author：Wikipedia 2025-08-26 23:48:27 - browse：258

BiTE Bridge — Illustration of a BiTE, Amgen's bispecific antibodies Amgen

In cancer immunotherapy these days, technology is advancing so fast that 2017’s buzzy new treatment may soon be passe: Only 18 months after approval of the first CAR-T, pharmaceutical companies and biotechs are already talking about next-generation cancer therapy.

Called bispecific antibodies, they’re being developed by some two dozen companies large and small, with a version cleverly branded as BiTEs already constituting 60 percent of Amgen’s oncology pipeline. The appeal: Bispecifics make the immune system kill tumor cells like first-gen immunotherapy, but, unlike the weeks it takes to laboriously manufacture CAR-Ts, they can start being infused almost as quickly as an oncologist can write a prescription.

“We’re very bullish” on BiTEs, said Dr. David Reese, head of R&D at Amgen, which has the only cancer-targeting bispecific approved for clinical use in the U.S. and 14 more in development, including for multiple myeloma, small cell lung cancer, glioblastoma, and other solid tumors. “We can generate a BiTE against any tumor antigen we want to go after.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Men with early prostate cancer can safely opt out of treatment

Wikipedia

explore

WSS

Men with early prostate cancer can safely opt out of treatment

Ionis drug prevents swelling attacks due to hereditary angioedema

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

explore

leisure time

entertainment

Guidelines to prevent youth baseball injuries need more muscle

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

In age of alternative facts, a scholarly course on calling out crap

Malaysia cuts short music fest after British band slams anti

Sports medicine is finally prioritizing gender equality

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

DIEP, the 'gold standard' of breast reconstruction, is under threat

New requirements coming in 2024 for Americans traveling to Europe

What does generative AI mean for health care? We asked experts

Novartis develops a rapidly manufactured CAR

hotspot

How to increase colonoscopy rates? Looks like an AI can help

Where does female orgasm come from? Scientists think they know

HIV drugs protect against transmission, even in unprotected sex

FDA's Pazdur wants cancer trials to range beyond China alone

Clinic falsely told dozens they had Alzheimer's, suits say

Severe heat forecast: Where scorching temperatures will persist over the next week

focus

Wikipedia

explore

explore